| Literature DB >> 27445318 |
Mitja N P Remus-Emsermann1, Pascal Gisler2, David Drissner3.
Abstract
Here we present the generation and function of two sets of bacterial plasmids that harbor fluorescent genes encoding either blue, cyan, yellow or red fluorescent proteins. In the first set, protein expression is controlled by the strong and constitutive nptII promoter whereas in the second set, the strong tac promoter was chosen that underlies LacI(q) regulation. Furthermore, the plasmids are mobilizable, contain Tn7 transposons and a temperature-sensitive origin of replication. Using Escherichia coli S17-1 as donor strain, the plasmids allow fast and convenient Tn7-transposon delivery into many enterobacterial hosts, such as the here-used E. coli O157:H7. This procedure omits the need of preparing competent recipient cells and antibiotic resistances are only transiently conferred to the recipients. As the fluorescence proteins show little to no overlap in fluorescence emission, the constructs are well suited for the study of multicolored synthetic bacterial communities during biofilm production or in host colonization studies, e.g. of plant surfaces. Furthermore, tac promoter-reporter constructs allow the generation of so-called reproductive success reporters, which allow to estimate past doublings of bacterial individuals after introduction into environments, emphasizing the role of individual cells during colonization. © FEMS 2016.Entities:
Keywords: CUSPER; Escherichia coli O157:H7; fluorescent proteins; reproductive success
Mesh:
Substances:
Year: 2016 PMID: 27445318 PMCID: PMC4972447 DOI: 10.1093/femsle/fnw178
Source DB: PubMed Journal: FEMS Microbiol Lett ISSN: 0378-1097 Impact factor: 2.742
Plasmids and bacterial strains used in this study.
| Name | Promoter and fluorescent gene | Antibiotic resistance | Reference |
|---|---|---|---|
| pGRG36 | Not applicable | Ampicillin | McKenzie and Craig ( |
| pUC18T-mini-Tn |
| Ampicillin, Zeocin | Choi and Schweizer ( |
| pUC18T-mini-Tn |
| Ampicillin, Zeocin | Choi and Schweizer ( |
| pMP7607 |
| Kanamycin | Lagendijk |
| pFru97 |
| Kanamycin | Tecon and Leveau ( |
| pRJaph_eBFP2 |
| Tetracycline | Ledermann |
| pRJaph_mtq2 |
| Tetracycline | Ledermann |
| pRJaph_mChe |
| Tetracycline | Ledermann |
| pCPP39 | Not applicable | Tetracycline | Leveau and Lindow ( |
| pMRE100 |
| Ampicillin | This study |
| pMRE101 |
| Ampicillin | This study |
| pMRE102 |
| Ampicillin | This study |
| pMRE103 |
| Ampicillin | This study |
| pMRE104 |
| Ampicillin | This study |
| pMRE105 |
| Ampicillin | This study |
| pMRE106 |
| Ampicillin | This study |
| pMRE107 |
| Ampicillin | This study |
|
| Chromosomally inserted, inducible mCherry gene | This study | |
|
| Chromosomally inserted, inducible eCFP gene | This study | |
|
| Chromosomally inserted, inducible eYFP gene | This study | |
|
| Chromosomally inserted, constitutive mCherry gene | This study | |
|
| Chromosomally inserted, constitutive eCFP gene | This study | |
|
| Chromosomally inserted, constitutive eYFP gene | This study | |
|
| Chromosomally inserted, constitutive eBFP2 gene | This study | |
|
| Chromosomally inserted, constitutive mTurquoise2 gene | This study |
Figure 1.Schematic representation of pMRE100-pMRE107 plasmids. The map shows pGRG36 including the insertion site of the different promoter FP constructs and other relevant features. araBAD promoter = arabinose-inducible promoter, tnsA-D = transposase genes, AmpR = ampicillin resistance conferring beta-lactamase, oriT = origin of transfer, pSC101 = origin of replication, Tn7 left end = left border of Tn7 transposon, MCS = multiple cloning site, Tn7 right end = right border of Tn7 transposon.
Primers used in this study.
| Primer name | Sequence 5′- 3′ | Tm* (°C) | Target and notes |
|---|---|---|---|
| Xho_Ptac_mChe.for | AAA ACT CGA GGG GGA ATT CTT GAC AAT TAA TCA TC | 60 | tac promoter; includes a 5′ XhoI restriction site |
| NotI_mChe.rev | AAA GCG GCC GCA AAA ACC GCC CTG CAA GG | 69 | mCherry; includes a 3′ NotI restriction site |
| Ptac_C/YFP.for | AAA ACT CGA GGG GGA ATT CTT GAC AAT TAA TCA TCG GCT CGT ATA ATG TGT GGA ATT GTG AGC GGA TAA CAA TTT TCA CAC AGG AAA CAG CTA AAT GCT GAG CAA GGG CG | 56 | CFP and YFP; the tac promoter is included in the primer |
| Ptac_C/YFP.rev | AAA AGC GGC CGC TAT TAC TTG TAC AGC TCG TCC ATG | 55 | eYFP and eCFP |
| Gib_Ptac+C/YFP.fwd | GTT TTA ATT AAT CAG ATC CCG GGA ATT CTT GAC AAT TAA TC | 48 | tac promoter; contains overlap to SmaI digested pGRG36 |
| Gib_Ptac+C/YFP.rev | GTG GCG GCC GCT ATT GAC CCT TAC TTG TAC AGC TCG TCC | 52 | eCFP and eYFP; contains overlap to SmaI digested pGRG36 |
| Gib_PnptII.fwd | CAC GTT TTA ATT AAT CAG ATC CCA ATT GGG GAT CGG AAG CTT GAC | 58 | nptII promoter from pFru97; contains overlap to SmaI digested pGRG36 |
| Gib_PnptII.rev | CCT TTG CTC ATA TGT TTT TCC TCC TTA TAA AGT TAA TCT TTA GTT AGT TAG GG | 59 | nptII promoter from pFru97; contains overlap to mCherry |
| Gib_mChe.fwd | GGA AAA ACA TAT GAG CAA AGG AGA AGA AGA TAA CAT GG | 58 | mCherry; contains overlap to the nptII promoter |
| Gib_mChe.rev | GGC CGC TAT TGA CCC TTA TTT GTA AAG CTC ATC CA | 47 | mCherry; contains overlap to SmaI digested pGRG36 |
| Gib_PnptII_C/YFP.for | GAA AAA CAT ATG CTG AGC AAG GGC GAG | 62 | eCFP and eYFP; contains overlap to the nptII promoter |
| Gib_PnptII_C/YFP.rev | CTG TAC AAG TAA GGG TCA ATA GCG GCC | 62 | eCFP and eYFP; contains overlap to SmaI digested pGRG36 |
| Gib_C/YFP_PnptII.rev | TGC TCA GCA TAT GTT TTT CCT CCT TAT AAA GTT AAT CTT TAG TTA GTT AGG G | 59 | nptII promoter from pFru97; contains overlap to eCFP and eYFP |
| Gib_PnptII_ngFPs.for | GGC CGC TAT TGA CCC TTA CTT GTA CAG CTC GTC CAT G | 55 | nptII promoter from pRJaph plasmids; contains overlap to SmaI digested pGRG36 |
| Gib_ngFPs.rev | CAC GTT TTA ATT AAT CAG ATC CCC ACG CTG CCG CAA GC | 55 | mTurquoise and eBFP; contains overlap to SmaI digested pGRG36 |
*Tm specific to the overlap to the specified targets, overlaps for isothermal assembly were designed to anneal at 50°C; ABR = antibiotic resistance: Amp = Ampicillin, Kan = Kanamycin, Zeo = Zeocin, Tet = Tetracycline.
Figure 2.Analysis of chromosomally inserted Ptac fluorescence protein gene labels using microscopy and microtiter plate reader. (A) Phase contrast and fluorescence micrographs of E. coli O157:H7 carrying chromosomally integrated Tn7-transposons containing mCherry, eCFP or eYFP encoding genes under the control of the lactose derepressible tac promoter. The left two columns show phase contrast and fluorescence images of non-induced cells, the right two columns show lactose-induced cells. For fair comparisons of fluorescence intensities and background, a linear contrast was applied to the images. (Exposure times for the respectively measured fluorophores are given in fluorescence micrographs, scale bar = 5 μm.) (B) Average single-cell fluorescence intensity per millisecond exposure after background subtraction. Non-induced cells are represented as white bars, and induced cells as black bars. Statistical differences in fluorescence intensity between treatments were assessed by performing a one-way ANOVA. ** = P < 0.01; **** = P < 0.0001. (C) Background-subtracted fluorescence of E. coli O157:H7 carrying the Tn7 insertions or wild-type cells cultivated under non-induced or induced conditions. Lines reflect floating averages of three replicates; stippled lines reflect the standard deviation of the mean.
Figure 3.(A) Phase contrast and fluorescence micrographs of E. coli O157:H7 carrying chromosomally integrated Tn7 transposons containing mCherry, eCFP, eYFP, eBFP2 or mTurquoise2 encoding genes under the control of the constitutive nptII promoter. The first column shows phase contrast images, the second corresponding fluorescence images (exposure times are given in the fluorescent images, scale bars = 5 μm). For fair comparisons of fluorescence intensities and background, a linear contrast was applied to the images. (B) Fluorescence intensity of E. coli O157:H7 carrying the Tn7 insertions or wild-type cells. Lines reflect the mean of three replicates; stippled lines reflect the standard deviation of the mean. (C) Average single-cell fluorescence intensity per millisecond exposure after background subtraction. Statistical differences in fluorescence intensity between treatments were assessed by performing a one-way ANOVA, and significant differences are indicated in the graph. **** = P < 0.0001.
Figure 4.Artificial mixtures of E. coli O157:H7 containing different Tn7-transposon inserted promoter fluorescent-protein labels. (A) A mix of induced E. coli O157:H7::MRE100, E. coli O157:H7::MRE101 and E. coli O157:H7::MRE102. Left image, phase contrast image, right image, false color overlay of mCherry (red), eYFP (green) and eCFP (blue). The contrast of each channel was adjusted. (B) A mix of E. coli O157:H7::MRE103, E. coli O157:H7::MRE105 and E. coli O157:H7::MRE107. Left image, phase contrast image; right image, false color overlay of mCherry (red), eYFP (green) and mTurquoise2 (blue). The contrast of each channel was adjusted. The scale bars represent 10 μm.